3/30付の米国FDAによるCOVID-19絡みガイダンス等の発出について、筆者のお好みでお伝えします。
関係者および興味のある方は、下記URLsの更新通知等をご参照ください。
l3/30付News Release「Coronavirus (COVID-19) Update: March 30, 2021」
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-march-30-2021
l3/30付New「SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests」
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-viral-mutations-impact-covid-19-tests
l3/30付Updated「Personal Protective Equipment EUAs」
https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/personal-protective-equipment-euas#imported
l3/30付Updated「Notifications and Emergency Use Authorizations: FAQs on Testing for SARS-CoV-2」
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/notifications-and-emergency-use-authorizations-faqs-testing-sars-cov-2
l3/30付Updated「Removal Lists of Tests that Should No Longer Be Used and/or Distributed for COVID-19: FAQs on Testing for SARS-CoV-2」
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/removal-lists-tests-should-no-longer-be-used-andor-distributed-covid-19-faqs-testing-sars-cov-2
［関連ニュース記事］
l3/30付BioPharmaReporter.com「COVID-19 vaccines ‘induce robust immune response’ in pregnant women: study」
https://www.biopharma-reporter.com/Article/2021/03/30/COVID-19-vaccines-induce-robust-immune-response-in-pregnant-women-study
関係者および興味のある方は、下記URLsの更新通知等をご参照
l3/30付News Release「Coronavirus (COVID-19) Update: March 30, 2021」
https://www.fda.gov/news-
l3/30付New「SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests」
https://www.fda.gov/medical-
l3/30付Updated「Personal Protective Equipment EUAs」
https://www.fda.gov/medical-
l3/30付Updated「Notifications and Emergency Use Authorizations: FAQs on Testing for SARS-CoV-2」
https://www.fda.gov/medical-
l3/30付Updated「Removal Lists of Tests that Should No Longer Be Used and/or Distributed for COVID-19: FAQs on Testing for SARS-CoV-2」
https://www.fda.gov/medical-
［関連ニュース記事］
l3/30付BioPharmaReporter.com「COV
https://www.biopharma-
執筆者について
経歴 ※このプロフィールは掲載記事執筆時点での内容となります
コメント
/
/
/
コメント